Labcorp Holdings Inc. Files 8-K
Ticker: LH · Form: 8-K · Filed: Dec 30, 2025 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Labcorp Holdings Inc. (LH) |
| Form Type | 8-K |
| Filed Date | Dec 30, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-disclosure, regulation-fd, exhibits
Related Tickers: LH
TL;DR
Labcorp filed an 8-K on 12/30/25 with corporate info and exhibits.
AI Summary
Labcorp Holdings Inc. filed an 8-K on December 30, 2025, reporting information under Regulation FD and including financial statements and exhibits. The filing details the company's principal executive offices located at 358 South Main Street, Burlington, North Carolina, 27215, with a business phone number of 336-229-1127. The company was incorporated in Delaware and previously operated under the names Laboratory Corp of America Holdings and National Health Laboratories Holdings Inc.
Why It Matters
This 8-K filing provides an update on Labcorp's corporate information and regulatory disclosures, which is important for investors and stakeholders to stay informed about the company's official reporting.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain information that suggests immediate financial or operational risk.
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Registrant
- 358 South Main Street, Burlington, North Carolina, 27215 (location) — Principal executive offices
- 336-229-1127 (phone_number) — Business phone number
- Laboratory Corp of America Holdings (company) — Former company name
- National Health Laboratories Holdings Inc (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report information under Regulation FD and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on December 30, 2025.
Where are Labcorp Holdings Inc.'s principal executive offices located?
Labcorp Holdings Inc.'s principal executive offices are located at 358 South Main Street, Burlington, North Carolina, 27215.
What is the business phone number for Labcorp Holdings Inc. listed in the filing?
The business phone number for Labcorp Holdings Inc. listed in the filing is 336-229-1127.
What were some of Labcorp Holdings Inc.'s former company names?
Some of Labcorp Holdings Inc.'s former company names were Laboratory Corp of America Holdings and National Health Laboratories Holdings Inc.
Filing Stats: 465 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-12-30 16:17:08
Key Financial Figures
- $0.10 — ange on which registered Common Stock, $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20251230.htm (8-K) — 26KB
- formpr123025ex991jpmorganh.htm (EX-99.1) — 5KB
- lc2020logov2.gif (GRAPHIC) — 5KB
- 0000920148-25-000125.txt ( ) — 151KB
- lh-20251230.xsd (EX-101.SCH) — 2KB
- lh-20251230_lab.xml (EX-101.LAB) — 21KB
- lh-20251230_pre.xml (EX-101.PRE) — 12KB
- lh-20251230_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced on December 30, 2025, that the Company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 4:30 p.m. (PT). A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein. A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press Release dated December 30 , 2025 issued by Labcorp Holdings Inc. Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant Date: December 30, 2025 By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary